Serum levels of VCAM‐1 are associated with survival in patients treated with nivolumab for NSCLC
出版年份 2021 全文链接
标题
Serum levels of VCAM‐1 are associated with survival in patients treated with nivolumab for NSCLC
作者
关键词
-
出版物
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2021-08-14
DOI
10.1111/eci.13668
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment
- (2020) A. Bonaventura et al. Clinical & Translational Oncology
- Mechanism and potential predictive biomarkers of immune checkpoint inhibitors in NSCLC
- (2020) Jialin Qu et al. BIOMEDICINE & PHARMACOTHERAPY
- New biomarkers for checkpoint inhibitor therapy
- (2020) Nikki Burdett et al. ESMO Open
- Updating concepts on atherosclerotic inflammation: from pathophysiology to treatment
- (2020) Stefano Ministrini et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Integrating Circulating Biomarkers in the Immune Checkpoint Inhibitor Treatment in Lung Cancer
- (2020) Boris Duchemann et al. Cancers
- Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study
- (2019) Aldo Bonaventura et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Effect and biomarker of Nivolumab for non–small-cell lung cancer
- (2019) Li Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer
- (2019) Federico Carbone et al. CLINICAL & EXPERIMENTAL METASTASIS
- Biomarkers for immune checkpoint inhibition in non–small cell lung cancer (NSCLC)
- (2019) J. Nicholas Bodor et al. CANCER
- The Significance of the PD-L1 Expression in Non–Small-Cell Lung Cancer: Trenchant Double Swords as Predictive and Prognostic Markers
- (2018) Kazuki Takada et al. Clinical Lung Cancer
- Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non‐Small Cell Lung Cancer Patients
- (2018) Matteo Sarocchi et al. ONCOLOGIST
- OUP accepted manuscript
- (2018) ANNALS OF ONCOLOGY
- Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function
- (2017) Alessandra Quercioli et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- A Human Antibody That Binds to the Sixth Ig-Like Domain of VCAM-1 Blocks Lung Cancer Cell Migration In Vitro
- (2017) Mi Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
- (2017) Lesley Seymour et al. LANCET ONCOLOGY
- Cell Adhesion Molecules, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor in Patients with Non-Small Cell Lung Cancer Treated with Chemotherapy with or without Bevacizumab--an Eastern Cooperative Oncology Group Study
- (2008) A. Dowlati et al. CLINICAL CANCER RESEARCH
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started